Shown: posts 1 to 2 of 2. This is the beginning of the thread.
Posted by sarai on March 19, 2001, at 14:07:08
Regarding a clinical trial I posted about the other day:
The prinicipal investigator is Dr. David Hellerstein, and the study is being conducted
at Beth Israel and was approved by their Institutional Review Board. The study will
also be expanded to St. Luke's Roosevelt Hospital Center in NYC in the next month
or two, after approval by the IRB.Thanks.
Posted by Dr. Bob on March 19, 2001, at 23:47:47
In reply to tx resistant clinical trial, posted by sarai on March 19, 2001, at 14:07:08
> Regarding a clinical trial I posted about the other day:
>
> The prinicipal investigator is Dr. David Hellerstein, and the study is being conducted
> at Beth Israel and was approved by their Institutional Review Board. The study will
> also be expanded to St. Luke's Roosevelt Hospital Center in NYC in the next month
> or two, after approval by the IRB.Fantastic, thanks for following up on that, and feel free to repost this to the main board. But maybe include what it is that's supposed to be tx resistant? :-)
Bob
This is the end of the thread.
Psycho-Babble Administration | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.